Skip to main content
. 2019 Feb 6;8(3):239–251. doi: 10.1530/EC-18-0485

Figure 4.

Figure 4

Nomograms predicting 1-, 2- and 3-year OS (A) and CSS (B) of patients with metastatic pancreatic neuroendocrine tumor. CSS, cancer-specific survival; OS, overall survival.